Login to Your Account


New target identified for treating TNBCs

By John Fox
Staff Writer

Wednesday, April 19, 2017

A collaborative study by Chinese and U.S. researchers has for the first time identified a critical new regulator of tumor growth, metastasis and immune response, which they showed to be an effective therapeutic target for triple-negative breast cancers (TNBCs) and potentially other cancers resistant to conventional treatments.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription